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Abstract
Understanding patterns and identifying common clusters of chronic diseases may help policymakers, researchers, and
clinicians to understand the needs of the care process better and potentially save both provider and patient time and cost.
However, only limited research has been conducted in this area, and ambiguity remains as those limited previous studies
used different approaches to identify common clusters and findings may vary with approaches. This study estimates the
prevalence of common chronic diseases and examines co-occurrence of diseases using four approaches: (i) identification of
the most occurring pairs and triplets of comorbid diseases; performing (ii) cluster analysis of diseases, (iii) principal
component analysis, and (iv) latent class analysis. Data were collected using a questionnaire mailed to a cross-sectional
sample of senior Australians, with 4574 responses. Eighty-two percent of respondents reported having at least one chronic
disease and over 52% reported having at least two chronic diseases. Respondents suffering from any chronic diseases had
an average of 2.4 comorbid diseases. Three defined groups of chronic diseases were identified: (i) asthma, bronchitis,
arthritis, osteoporosis and depression; (ii) high blood pressure and diabetes; and (iii) cancer, with heart disease and stroke
either making a separate group or ‘‘attaching’’ themselves to different groups in different analyses. The groups were largely
consistent across the approaches. Stability and sensitivity analyses also supported the consistency of the groups. The
consistency of the findings suggests there is co-occurrence of diseases beyond chance, and patterns of co-occurrence are
important for clinicians, patients, policymakers and researchers. Further studies are needed to provide a strong evidence
base to identify comorbid groups which would benefit from appropriate guidelines for the care and management of
patients with particular disease clusters.
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Introduction
Multimorbid and comorbid chronic diseases are increasingly
placing a greater burden on individuals, communities and health
care services. With ageing of the population and longer survival,
scientific advances in medical care and public health policy, a
growing proportion of the population is surviving longer with
multiple chronic diseases. It is also increasingly recognised that
diseases tend to occur together leading to a rising interest in the
‘common pathways’ implicated in the clustering of diseases and
required responses to the potential to help better organise medical
responses [1–3]. This co-occurrence of diseases has implications
from a disease management point of view, as the features of
comorbid diseases can be much more complicated than a simple
aggregation of individual illnesses [4]. It also has implications for
studies which explore the implications of chronic diseases, as for
many people the impact of multiple diseases compound and
interact. Hence using a single-morbidity model – where the impact
of a single disease is explored – may mean one fails to grasp the
pattern of disease, leading to inadequate clinical management, or
to inadequate understanding of the disease effect by researchers
and policymakers.
Although the need to understand the patterns of disease
combinations/clusters and associated complexity and care is well
recognised [5], research conducted on these issues remains limited.
Concern exists about increased time and cost requirements for
both the individual and the health care system [6–8] caused by
comorbidities. Identifying common clusters may improve under-
standing of these effects and enable policymakers and clinicians to
work towards simplifying the care process, and saving patients
time and costs. A recent study of working Australians found
multimorbidity is increasingly prevalent in Australia [9]. A
systematic review of Australian studies on multimorbidity endeav-
oured to identify prevalent groups of co-occurring diseases and
found almost a third of the studies included scored only 50% using
the critical appraisal tool, highlighting the need for increased
research with greater methodological rigour [10].
Studies of comorbidity have used different analytic approaches,
some used simple disease counts, some performed cluster analysis
and others used factor analysis or correspondence analysis [11–
16]. Use of different approaches has led to a fragmented and
incomplete understanding of the nature and impact of multi-
morbidity. Moreover, study findings may vary with approaches
[17]. Problems also arise in comparing methods across studies as
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some are based on self-report and some on clinical records, some
use very comprehensive lists of diseases and some relatively few
diseases. Few of those studies increased the reliability of their
findings by comparing methods to establish difference in outcomes
using different approaches [18]. Existing literature reveals no
consensus about how the co-occurrence of diseases should be
measured [19,20]. There remains a clear lack of an internationally
accepted standard for assessing which diseases are likely to co-
occur.
This study aimed to identify the pattern of co-occurrence of
common chronic diseases in senior Australians, and also to explore
whether and how the patterns identified differed if different
analytic methods were used. By applying different methods to a
single data set, issues of data collection and comprehensiveness of
lists of conditions are avoided. A high degree of consistency in the
results would provide confidence in the patterns, a lack of
consistency would lead to questions about the ‘‘best’’ approach.
This study used four analytical approaches: (i) identifying the
most frequently occurring pairs and triplets of comorbid diseases;
performing (ii) cluster analysis of diseases, (iii) principal component
analysis, and (iv) latent class analysis. The paper also examines the
possible methodological reasons for consistency (or variation) in
findings across the methods. We go on to discuss comorbid
patterns from the point of clinical epidemiology, and question the
way in which this knowledge might inform clinical management.
Methods
Setting and respondents
The study population are members of the National Seniors
Australia, a nation-wide organisation with 285,000 members aged
50 years and over. An opt-in invitation and a study questionnaire
were mailed to a representative cross-section of their membership
base (n=10,000) during mid-2009. The questionnaire was piloted
and revised before mailing to the respondents. The sample was
stratified by age, rurality and state of residence, with those aged 75
years or older over-represented to permit analysis of this older
cohort. Survey questions were drawn from existing validated tools
(for details see McRae et al., [6]). The survey and study were
approved by the Australian National University Human Research
Ethics Committee (no. 2009/309). All respondents provided
informed consent to participate by returning completed question-
naires. The Ethics Committee approved this consent procedure.
Data about chronic illnesses were collected using a list of 11
diseases (Table 1). Respondents were asked ‘Has a doctor ever told
you that you had any of the following illnesses?’ This was followed
by the list of diseases. The final open question asked the
respondent to nominate any other long-term condition that had
been diagnosed. This study focused on a sub-set of those
conditions comprising the most common serious chronic diseases
in Australia [21]: cancer, heart disease, high blood pressure (HBP),
stroke, asthma/hayfever, bronchitis/emphysema, diabetes, arthri-
tis, osteoporosis, Parkinson’s disease, depression (including anxi-
ety).
All prevalence estimates are weighted to reflect the age, sex, and
State structure of the Australian population. We used four
approaches (expected/observed prevalence ratios, cluster analysis,
principal component analysis and latent class analysis) to explore
whether diseases were independent of each other, and if not,
whether there are any common patterns of grouping across the
approaches. We did not use any weighting in these analyses.
Prevalence of comorbidity and probability of particular
groupings
The presence of disease is reported as frequency and prevalence
(per 100 persons) of occurring (independent of any comorbidity).
The mean number and standard error of co-occurring diseases
(apart from the index condition) were estimated.
The prevalence of the most common disease pairs with observed
prevalence of $5% was estimated, and whether these prevalences
were greater than would be expected if the two diseases were
independent was tested using a Chi-square test, and further tested
by logistic regressions between each pair of co-occurring diseases
with and without adjustment for age, sex, education, and all of the
other diseases. Ratios between observed versus expected were also
calculated and are reported. Similarly a list of three diseases
(triplets) that coexisted within the same respondent was examined
and most common triplets were counted in terms of absolute
frequency and per 100 respondents. Chi-square testing was
undertaken with the triplets to assess whether observed preva-
lences differ from expected ones, but no logistic regression was
conducted.
Method of clustering
Data on chronic diseases were collected as binary objects, taking
the value of ‘1’ when a given disease was present and ‘0’ when it
was absent. Our basic interest is in identifying clinically
meaningful clusters of chronic illnesses based on their relative
similarity or dissimilarity (also known as distance). Our dataset is a
collection of binary objects arranged in an n6p matrix with rows
representing the n ( = 4574) respondents and columns representing
the p ( = 11) chronic diseases. The classical approach to cluster
analysis is to classify n respondents into a set of clusters based on
index of proximity among the respondents, yielding an n6n
proximity matrix reflecting the degree of closeness among the
respondents to see if they comprise clusters of diseases. However, it
is also possible to cluster variables (chronic diseases) and produce
groupings of chronic diseases based on the relative proximity of
variables. The problem simplifies to reducing the transposed p6n
data matrix to a much smaller p6p proximity matrix among the
chronic illness diseases, rather than a potentially large n6n
proximity matrix [11]. We have undertaken both clustering
approaches.
As many chronic diseases share the same underlying genetic,
environmental or behavioural risk factors, analysing clusters of
variables using the hierarchical clustering approach was appro-
priate. Under this method, each individual disease begins as an
individual cluster which is gradually merged with the most closely
related other clusters until a single cluster containing all
comorbidities is obtained. We chose this agglomerative approach
as we did not know the possible number of clusters a priori, and
the number of clusters was assessed using a dendrogram, and
agglomerative coefficient. To measure the distance between two
clusters we used the average linkage method [22] to accommodate
the spread of the clusters.
In the context of cluster analysis for grouping of observations a
partitional clustering with k-medoids was performed. This
clustering process starts by randomly assigning objects to a
number of clusters. Unlike the hierarchical clustering approach,
where an object remains in a cluster once it is assigned to it, the k-
medoids proceeds with iteration. The objects are then successively
reassigned to other clusters to minimize the within-cluster
variation. If the reallocation of an object to another cluster
decreases the within-cluster variation, this object is reassigned to
that cluster, and this iteration continues until it reaches to the least
within cluster variation [23]. We used STATA cluster stopping
Multimorbidity and Comorbidity of Chronic Diseases
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rule with the Calinski–Harabasz pseudo-F index to determine the
appropriate number of groups [24].
For cluster analysis (both for observation and variable cluster-
ing) with binary data a number of similarity measures have been
used in the literature; Jaccard coefficient and Yule’s Q were
commonest among them. The choice of similarity measure
depends on the relative weight given to positive and negative
matches, which in turn depends on the relative importance of
positive and negative matches [22]. In the Jaccard similarity,
negative matches (in a 262 table the frequency of the cell that
presents group having neither of the diseases) are virtually non-
informative [11] and receive zero weight, whereas positive
matches and non-match elements receive equal weights. However,
negative matches are considered informative in Yule’s Q. In fact,
negative matches are also part of calculation of tetrachoric
correlations used in our principal component analysis. As one of
our aims is to see if different approaches produce same results, to
ensure consistency across the approaches, we used the Yule’s Q as
the similarity measure in both forms of cluster analysis.
Chronic diseases with very low prevalence (,2.0%) were
excluded from analyses to minimise sequential joining of low
prevalence comorbidities into existing clusters [22]. As part of
checking stability the dataset was split into two halves and the two
subsets were analysed separately using the same parameter
settings. Sensitivity of clusters/groups was also tested by observing
changes (if any) of pattern of clusters due to exclusion of individual
diseases from the analysis.
Principal component analysis
A standard principal component analysis was performed with a
varimax rotation applied to facilitate interpretation of component
loadings. The aim of this analysis is to summarize the observed
variables into a reduced set of variables. As the variables are
dichotomous the analysis was based on a correlation matrix
populated with tetrachoric correlations which are more appropri-
ate than Pearson correlations in this context [25]. The optimal
number of components was determined using a number of indices
including the scree test, the Eigenvalues-greater-than-one rule,
standardized root mean square residual; comparative fit index and
Tucker Lewis index. The criterion for factor loading was set at
$0.30.
Latent Class Analysis
Latent class analysis was used to classify objects or individuals
according to their distribution on 10 chronic diseases. Like cluster
analysis, it is aimed at identifying clusters (classes) of individuals
that are in some sense ‘similar’. However, there is no need to
define cluster distance (or similarity), nor to select cluster
algorithms (e.g. agglomerative); rather latent class analysis classifies
objects according to the probabilities of the observed values of all
variables for each object [26]. For identifying an optimal baseline
model a sequence of models was examined with two classes, three
classes, and so on. A range of indices was used for model selection,
including the likelihood-ratio G2 statistic, and Bayesian Informa-
tion Criterion (BIC). In addition, model interpretability was
considered, for example, distinguishability of each class from the
others on the basis of the item-response probabilities, triviality in
size (i.e., no class should have a near-zero probability of
membership), and the possibility of assigning a meaningful label
to each class.
An iterative maximum likelihood estimate was used, which
requires ‘random’ starting values. The estimate was repeated with
a different set of ‘random’ starting values. Models were identified
that had a frequently occurring dominant solution. Solutions were
considered to be identical if the log likelihood and parameter
estimates were replicated [26].
Data were analysed using STATA (version 12), SPSS (version
20) and SAS (9.3).
Results
Demographic characteristics
A total of 4,574 people returned the completed survey. The
overall response rate was 45.7%, with little difference between
male and female response rates (45.1% to 46.3%). The average
age of respondents was 69.3 years. Only 15 respondents identified
themselves as of Aboriginal or Torres Strait Islander descent. Most
respondents (77%) were born in Australia. More than half of the
respondents had post-school qualifications. Sixty percent were
completely retired or pensioners. Eighty percent had current
private health insurance. The study sample was similar to the
Australian population on most of the demographic characteristics
except that the sample members were better educated, reported
Table 1. Prevalence of Selected Chronic Diseases.
Diseases n
Weighted prevalence
(%) % with comorbidity Co-occurring diseases mean±SEA
Cancer 868 17.9 84.8 2.160.05
Heart disease 724 12.3 90.1 2.360.06
High blood pressure 2047 43.1 82.1 1.860.03
Stroke 179 3.2 96.1 2.860.12
Diabetes 563 12.8 89.7 2.260.06
Asthma/hayfever 773 18.2 88.0 2.260.05
Bronchitis/Emphysema 191 3.4 97.4 3.060.11
Arthritis 1597 32.2 87.7 2.060.03
Osteoporosis 531 9.3 90.8 2.360.06
Parkinson’s disease 39 0.60 89.7 2.660.27
Depression and anxiety 625 15.3 92.8 2.460.06
Other 1218 25.4 87.8 2.060.04
Aother comorbid diseases apart from those mentioned in column 1.
doi:10.1371/journal.pone.0083783.t001
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better health and were more likely to have private insurance
coverage than the average Australian in their age range. The
estimated prevalence of chronic disease in the study population
was also similar to the Australian population prevalence in this age
group, although respondents reported a higher prevalence of high
blood pressure, history of cancer diagnosis and a lower prevalence
of arthritis [6].
Prevalence of chronic diseases and comorbid diseases
Eighty-two percent of respondents reported having at least one
chronic disease and over 52% having at least two chronic diseases.
Female respondents reported a significantly higher number of
diseases than male respondents. Of those respondents aged over
75 years, 93% experienced at least one chronic disease and 73%
more than one chronic disease. Overall, 27% reported at least
three chronic diseases, 11% at least four and 3% at least five
diseases. High blood pressure (HBP) (43.1%), arthritis (32.2%) and
cancer (17.9%) were three most prevalent diseases (Table 1).
Respondents who had any chronic disease had an average of 1.5
(SE60.02) additional comorbid diseases. The number of comorbid
diseases varied from an average of 1.8 to 2.6 between the various
index conditions (last column, Table 1). Comorbidity was highest
among those with chronic bronchitis/emphysema (97%) and
lowest among those with HBP (82%).
Table 2 presents the observed and expected prevalence of the
most frequently co-occurring pairs of diseases and their crude and
adjusted odds ratios. Most diseases of these pairs were identified as
the most prevalent in Table 1. Six of the eleven pairs with a
prevalence of over 5% show a statistically significant relationship
(meaning more are observed than would be expected at random
from the prevalence of the components of the pairs). HBP and
diabetes were the pair of diseases with the strongest association
reflected by the adjusted odds ratio followed by arthritis and
depression, and asthma/hayfever and arthritis. Adjustment for age,
gender, education, income, and region did not influence the
relationships with the larger odds ratios but did change a number
of weaker effects (in both directions).
Leading multimorbid triplets
The weighted prevalence of three way combinations of diseases
(triplets) shows that the three most common triplets are HBP,
asthma/hayfever and arthritis (4.3%), HBP, arthritis and depression (3.7%)
and cancer, HBP and arthritis (3.5%) (Table 3). Clearly, the most
common triplets were determined by respondents having highly
prevalent chronic diseases such as HBP and arthritis (all 15 triplets
had either of these two diseases and five triplets have both of
them). The ratio of observed to expected value was highest for the
asthma-arthritis-depression triplet, followed by the heart disease-HBP-
diabetes (Table 3).
Cluster analysis
(i) Variable clustering approach. As the prevalence of
Parkinson’s diseases was less than 2%, it was not included in any
further analysis. Figure 1 presents a dendrogram of the variable
based cluster analysis using average linkage and Yule’s Q similarity
measure. Stepwise agglomerative coefficients suggest a three
cluster solution is most feasible. The change in the agglomerative
coefficient when stepping from 3 to 2 groups is at least twice as
large as for any other step. Heart disease and stroke had the smallest
distance and thus formed the first cluster, which joined to another
cluster comprised of HBP and diabetes, and finally are reflected as a
four-disease cluster (heart disease, stroke, HBP and diabetes). Asthma and
bronchitis formed the second cluster which then joined by depression
at a relatively higher distance. Arthritis and osteoporosis then added to
that cluster in the next step, finally making a five-disease cluster.
Cancer alone runs all the way through the process without linking
with other diseases until it merges to the heart disease-stroke-HBP-
diabetes cluster at a relatively large distance, meaning cancer
becomes part of this cluster at a very low similarity value. The
three cluster solution suggested by dendrogram would be:
N Cluster 1: asthma, bronchitis, arthritis, osteoporosis and
depression (including anxiety)
N Cluster 2: heart disease, stroke, HBP and diabetes
N Cluster 3: cancer
Table 2. Persons affected by the most frequently co-occurring pairs of chronic diseases and their observed and expected
prevalence per 100 population.
Frequent co-occurring pairs n Prevalence/100 Chi2 (p value)B
Odds Ratio (from Logistic
regression) (95% CI)
Observed ExpectedA
Observed/
Expected Crude Adjusted
HBP and Arthritis 826 18.05 15.62 1.16 9.8 (,0.01) 1.5 (1.4–1.7) 1.4 (1.2–1.6)
HBP and Cancer 401 8.77 8.49 1.03 0.2 (0.63) 1.1 (0.9–1.2) 0.9 (0.8–1.1)
HBP and Heart disease 381 8.33 7.08 1.18 5.0 (0.02) 1.5 (1.2–1.7) 1.1 (0.9–1.3)
Asthma/hayfever and arthritis 367 8.02 5.90 1.36 15.9 (,0.01) 1.9 (1.6–2.2) 1.6 (1.4–1.9)
HBP and Diabetes 365 7.98 5.51 1.45 22.2 (,0.01) 2.5 (2.1–3.1) 2.4 (2.0–2.9)
HBP and Asthma/hayfever 348 7.61 7.56 1.01 0.01 (0.94) 1.0 (0.9–1.2) 1.0 (0.8–1.2)
Cancer and Arthritis 319 6.97 6.62 1.05 0.44 (0.51) 1.1 (0.9–1.3) 1.0 (0.8–1.2)
Arthritis and DepressionC 307 6.71 4.77 1.41 16.0 (,0.01) 2.0 (1.7–2.4) 1.9 (1.6–2.3)
HBP and DepressionC 304 6.65 6.11 1.09 1.1 (0.28) 1.2 (1.0–1.4) 1.2 (1.0–1.5)
Heart disease and Arthritis 284 6.21 5.51 1.13 2.0 (0.15) 1.2 (1.1–1.5) 1.1 (0.9–1.3)
Arthritis and Osteoporosis 257 5.62 4.05 1.39 12.3 (,0.01) 1.9 (1.6–2.3) 1.3 (1.1–1.6)
AMultiplication of observed prevalences of individual disease;
BTest of independence for observed and expected prevalences;
Cincluding anxiety.
doi:10.1371/journal.pone.0083783.t002
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(ii) Cluster of observations. Following the partitional k-
medoids approach four groups were identified (Table 4). These
groups were identified by combinations of diseases, and we now
label the clusters which we call Groups to distinguish from variable
cluster according to the dominant diseases in each group. For
instance, 46% of the respondents with HBP fell in Group 2 with
the rest in Group 1 (23%), Group 3 (16%) and Group 4 (15%).
Thus for the purpose of clustering respondents with HBP were
labeled as belonging to Group 2.
Group 2 was also the dominant group for diabetes, and hence
we describe Group 2 as HBP and diabetes. Similarly, for asthma,
bronchitis, arthritis, osteoporosis and depression the dominant
group was Group 1, while heart disease and stroke identified
Group 3 and cancer alone formed a separate group. Percentages
of observation in each of the four groups are shown in Table 4.
Principal component analysis
Iterations produced three Eigenvalues greater than 1 as shown
in the scree chart (Figure 2). All of other indices also suggest a
three components solution. Loadings exceeding the cut-off 60.30
are reflected in Table 5. The following three components were
identified with loading .60.30:
N Component 1: asthma, bronchitis, arthritis, osteoporosis and
depression (including anxiety)
N Component 2: cancer, heart disease and stroke
N Component 3: HBP and diabetes
The three principal components we identified do not have any
overlapping diseases and give us three clear clusters of diseases. Of
the 10 diseases available for analysis in our study, we found
loadings were highest for HBP and diabetes followed by those for
heart disease and stroke.
Classes identified using latent class analysis
The drop in likelihood ratio G2 relative to the drop in degrees of
freedom is substantial with each additional class up to the four-
class model; the addition of classes beyond four provides essentially
no improvement in fit. Adjusted BIC values (one-class model:
1361; two-class: 1025; three-class: 916; four-class: 909; five-class:
932; six-class: 961) agreed with the G2 statistics. Thus four latent
classes were identified, and labelled as (i) relatively healthier group,
(ii) group with dominant presence of arthritis, asthma and
depression, (ii) group with dominant presence of HBP and
diabetes, and (iv) group with dominant presence of cancer, heart
and stroke. Very small values of item-response probabilities (rho
parameters) of ‘relatively healthier’ group suggest none of the 10
Figure 1. Dendrogram of likely clusters using variable clustering of 10 chronic diseases.
doi:10.1371/journal.pone.0083783.g001
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diseases are prevalent in this group. However, relatively higher
values of item-response probabilities for other three groups suggest
these diseases are strongly associated with each other in those three
individual groups. Item response probabilities of bronchitis and
osteoporosis are same in two groups (column 3 and 5, Table 6).
Based on the clinical nature of the diseases, we have grouped
bronchitis with asthma and osteoporosis with arthritis. Thus, in
terms of grouping of diseases we found three meaningful classes, as
described above.
Table 7 presents probable clusters identified through two cluster
analysis methods, principal components, latent class analysis and
the top three associated triplets. The patterns of the clusters which
emerged from the two clustering methods appear to be similar in
terms of disease grouping, except for heart disease and stroke which,
while always together, form a separate group in observation based
clustering, and change group in principal component analysis.
Notably, in both clustering methods cancer sits alone separately,
but is grouped with heart disease and stroke in the principal
component analysis. There is a great similarity between the
groups found from clustering of observations and principal
component analysis, again the exception being heart disease and
stroke. There was also consistency between the groups identified
using principal component analysis and latent class analysis.
Overall, Table 7 suggests there are three well defined groups of
chronic diseases: (i) asthma, bronchitis, arthritis, osteoporosis and
depression; (ii) HBP and diabetes, and (iii) cancer, with heart disease and
stroke either making a separate group or ‘attaching’ themselves to
different groups in different analyses.
In the sensitivity test exclusion of individual diseases from the
analysis did not change the patterns of grouping in variable
clustering, principal component analysis or latent class analysis.
However, in clustering observations, low prevalence diseases such
Table 4. Identification of groups in k-medoids clustering approach.
Disease n % of respondents belong to individual groups
Group1 Group2 Group3 Group4
Cancer 868 0 1 18 82
Heart 724 3 3 91 3
HBP 2047 23 46 16 15
Stroke 179 19 25 41 15
Diabetes 563 9 59 19 13
Asthma 773 38 37 7 17
Bronchitis 191 36 28 19 17
Arthritis 1597 64 5 15 16
Osteoporosis 531 53 16 14 18
Depression and anxiety 625 51 21 11 17
% total in each group 26.4 43.4 14.7 15.5
doi:10.1371/journal.pone.0083783.t004
Figure 2. Scree test with Eigenvalues for range of factors.
doi:10.1371/journal.pone.0083783.g002
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as stroke were found to sometimes move to another group when
some diseases were omitted, and diseases for which one group was
only marginally dominant over another (e.g. 38% of asthma
respondents belongs to Group1 and 37% to Group2) sometimes
moved to the group that had the second highest number of
respondents. As mentioned earlier, for checking stability, the
dataset was split into two halves; separate analyses with those two
subsets using the same parameter settings produced consistent
grouping of diseases.
Discussion
This study confirms that HBP and arthritis, the two leading
chronic diseases, are dominant in major comorbid pairs and
multimorbid triplets among older Australians. As observed, while
some pairs and triplets are more prevalent than would be the case
if the diseases were independent, the measurements based on pairs
and triplets are mostly guided by the prevalence of the individual
diseases, and they are mainly important for identifying the most
numerous groups of patients. Findings from the multivariate
approaches regarding patterns of comorbidity were largely
consistent, even when the dataset was split into two halves and
after exclusion of individual diseases. Overall, our study demon-
strates that while different analytical methods can lead to
somewhat different associations; there is broad consistency in
associations across the multiple modes of analysis. In general, it is
difficult to compare our results with findings of other studies of
similar type because there remain variations in data sources and
structures, populations and diseases studied [27]. However, overall
prevalence of comorbidity and multimorbidity of our study are
consistent with the reported range of multimorbidity rates in
elderly populations [28–30].
While the results provided in Table 7 show considerable
consistency across the analytic methods, there are some differences
which reflect the different analytic approaches. The major
difference in the methods is between the cluster analyses which
are based on distance measures, and the principal components and
latent class analyses which are based on correlations. The results in
the latter two approaches are in fact the same, but are different
from the distance-based approach in that cancer is in a group of its
own, while in the correlation-based groups cancer is linked with
heart disease and stroke. This may arise because the proportion of
participants with the heart disease and stroke pair who reported having
cancer was 31%, which is higher than the proportion of cancer
reported by the participants with other pairs.
Within the cluster analyses, since we used same distance
measure (Yule’s Q) for both approaches, it is not surprising that
the results are quite similar, with the only difference being that the
heart-stroke-HBP-diabetes group in the variable clustering ap-
proach is split in the observation clustering approach (see Table 7).
Looking at the dendrogram in Figure 1 we see that this group even
in the variable clustering process comprises the same two pairs of
conditions as are found in the observational clustering. The
different approaches therefore basically generate similar group-
ings, but the nature of the ‘‘cutoffs’’ lead to slightly different final
groups in our study. Despite utilising different methods (agglom-
erative hierarchical clustering and k-medoids) which approach the
problem from different angles, we found consistency in the
groupings.
As mentioned earlier, heart disease and stroke formed a cluster in
their own right in the hierarchical method and were found
strongly correlated in the principal component analysis. The most
strongly associated comorbid pair in principal component analysis
Table 5. Loadings with values .|0.3|.
Variable Component 1 Component 2 Component 3
Cancer 0.4740
Heart 0.6091
HBP 0.6041
Stroke 0.5136
Diabetes 0.6288
Asthma 0.5462
Bronchitis 0.4536
Arthritis 0.4282
Osteoporosis 0.3063
Depression and anxiety 0.4497
doi:10.1371/journal.pone.0083783.t005
Table 6. Item-response probabilities for four class model: probability of individual diseases in latent class.
Item Relatively healthier
Sick group with
dominant presence of
arthritis, asthma and
depression
Sick group with
dominant presence of
HBP and diabetes
Sickest group with
dominant presence of
cancer, heart and stroke
% of respondents in the group 55.5 19.4 13.0 12.1
Cancer 0.17 0.17 0.13 0.34
Heart 0.12 0.04 0.13 0.54
HBP 0.27 0.42 0.99 0.69
Stroke 0.01 0.01 0.05 0.19
Diabetes 0.07 0.07 0.32 0.23
Asthma 0.08 0.44 0.06 0.23
Bronchitis 0.00 0.11 0.01 0.12
Arthritis 0.21 0.60 0.38 0.55
Osteoporosis 0.07 0.23 0.04 0.23
Depression and anxiety 0.06 0.31 0.13 0.20
doi:10.1371/journal.pone.0083783.t006
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was HBP and diabetes. This outcome is consistent with those from
previous studies; that these conditions share significant underlying
risk factors and associated common complications [31]. Another
strongly associated pair – arthritis and depression – is also supported
by an increasing body of research, although the causality
mechanism by which arthritis may lead to depression or vice
versa remains unclear [32].
Some diseases (e.g. heart disease and stroke) appear in different
groupings in the different analyses, and this is clinically feasible, as
there could be same underlying factors for a number of chronic
diseases [1]. However, the number and the overall pattern of
clusters (Table 7) are broadly consistent. In both of the clustering
approaches we found cancer to stay in a separate cluster. This
appears to be reasonable as cancer is a disparate group of diseases
[18]. Although the most common risk factors for cancer, such as
age, smoking, poor diet, obesity and physical inactivity, are shared
by many other comorbidities of interest [33], risk factors for a
specific cancer may be unique.
One of the major strengths of our study is that we used a range
of analytical methods, and that our dataset was relatively large.
Whatever consistency (or discrepancy) we observed was validated
by the findings of four different approaches. In cluster analysis
subject-expertise and judgment are often needed for assessing
number and consistency of clusters. Our use of several statistical
approaches reduced the heavy reliance on subjective judgment.
Although data for the chronic diseases were binary, the use of
tetrachoric correlations for principal component analysis addresses
this concern. The observed degree of differences in results between
the approaches is mostly explained by the underlying statistical
formulae. Our use of latent class analysis reduced the reliance on
choice of similarity measure in cluster analysis, the choice of which
is often subjective in the literature. There were, of course, some
minor judgments to be taken in the latent class analysis. The
consistency of groups identified through the latent class analysis
further substantiated the findings and supported the stability of the
grouping of diseases.
It is difficult to directly compare our findings with those of the
previous studies since the results depend on a range of factors
including number and type of diseases included, the demographic
and underlying risk-factors of the sample, and the mode of
collection of the information. Despite this complexity, meaning
that results will be different, it is important to present some of our
findings in relation to both prevalence of particular comorbidities
and the structure of comorbidity alongside the findings of selected
previous Australian studies. In a study of the consultations
provided by a sample of Australian general practitioners in
2005, Britt et al. [17] found that combination of arthritis/chronic
back pain and vascular disease was the most common comorbidity
(15.0% of sample). Our observation that the most common
combination was HBP and arthritis (18.05 of sample) reflects
broadly similar conditions. Age is likely to be one of the major
factors explaining the differences between our study and that of
Britt et al. [17], who studied all the patients attending a GP
irrespective of their age, whereas our respondents were aged 50
years or older. In a systematic review with studies of chronic
diseases among the elderly population in Australia, Caughey et al.
[10] reported that over half of the elderly patients with arthritis
also had hypertension and over 60% of patients with asthma
reported arthritis as a comorbidity. Our observations are similar to
the former combination, although a little less than the latter.
In a study of working Australians, Holden et al. [9] identified six
clinically meaningful groups and found that observed clusters did
not fall neatly into organ systems, and some diseases appeared in
more than one cluster. There was a certain degree of similarity
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between the findings of Holden et al., (2001) and our study. For
instance, asthma and chronic obstructive pulmonary disease were
found to have been in a group, together with allergies which we
did not identify as a separate disease, and like our study HBP and
diabetes were found to remain together.
The difficulty in comparing findings from studies concerning
comorbidity and multimorbidity is of central concern to policy-
makers and clinicians, who seek to improve health service delivery
and management of people living with comorbid and multimorbid
illness. Our study offers multiple methodological approaches to
understanding the associations between specific diseases, which is a
first and essential step towards enabling policymakers and
clinicians to reach their goal. While our study demonstrates that
different analytical methods can lead to different associations, it
also demonstrates broad consistency in associations across multiple
modes of analysis. Future initiatives to improve policy and service
delivery for management of comorbidity and multimorbidity
should therefore pay close attention to the methods employed in
research that underpin policymaker and clinician decision making.
If studies can demonstrate that associations remain strong using
multiple modes of analysis this will strengthen the validity of study
findings, and better inform those who would seek to utilise them.
In Australia, the health system remains largely single-illness
oriented despite the prevalence of comorbidity and multi-
morbidity [34]. This disease-specific strategy can result in
fragmentation of care and will often not address the complex
needs of patients with multimorbidity. Initiating systemic changes
will require, as a starting point, a strong evidence base that
identifies those associated diseases, in order to develop programs of
care that cater to such associations and ultimately meet the
complex needs of patients with multimorbidity.
Limitations
A major difference between comorbidity studies is the selected
list of diseases, and whether they are self-reported or clinically
derived [11–16]. Our analysis was based on a set of limited
number of self-reported diseases. The prevalence and pattern of
comorbidity might have been different had other chronic diseases
been included. The accuracy of reported diagnoses is untested,
and may be inaccurate for many reasons, including imperfect
communication by health professionals, or imperfect memory or
understanding by the respondent. There may have been an effect
of participants’ education levels on correctly understanding and
remembering the chronic conditions, which would also influence
their answers and potentially the final pattern of the groupings.
However, there may also be a relationship between education
levels and the diseases actually experienced, and it is not possible
to separate the response effects from the clinical effects. While self-
reported identification of chronic diseases is criticized by some
authors [17] it was found by others to be a well-established method
for the measurement of comorbidity and/or multimorbidity [35].
Cluster analysis involves a series of analytic decisions – for
instance, about the type of algorithm to be used, measure of
similarity (or dissimilarity) to be used, whether clustering is to be
done for objects or variables – all these can have an influence on
the final results. To address the impact of these decisions we used
both object and variable clustering. Moreover, the similarity of
groupings between the two clustering procedures and overall
similarity of pattern of groups identified using principal compo-
nent analysis and latent class analysis substantiate the view that our
analytical decisions in cluster analysis were appropriate. Although
we have endeavored to compare our results with those of similar
studies, this comparison is limited by selection of diseases and
population age, as outlined above.
Conclusion
Comorbidity and multimorbidity are an increasingly recognised
part of the leading public health problem of managing chronic and
complex illness. This area requires more attention and better
research. Identification of comorbidity patterns offers valuable
information to the stakeholders of health delivery systems and can
potentially pave the way to more appropriate health care
associated with the pattern and types of multiple diseases. Our
results in Table 7 suggests there are three defined groups of
chronic diseases: (i) asthma, bronchitis, arthritis, osteoporosis and depression
& anxiety; (ii) HBP and diabetes, and (iii) cancer; with heart disease and
stroke either making a separate group or ‘attaching’ themselves to
different groups in different analyses. These findings identified
with a range of approaches contribute to a better understanding of
the complexity of multimorbidity by characterizing the association
between diseases in multiple ways. This study identified some
clinically meaningful clusters of multimorbid diseases. However,
further studies are needed to provide a strong evidence base on
which to formalise groupings which can be more widely used to
assist in our understanding of the implications of different
comorbidities.
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